BioventusBVS

那斯達克 · USD
13.63
-0.20
(-1.45%)
收盤 09/10 03:59 (UTC+8)
09/10 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.29
  • 1.51
  • 1.39
  • 1.54
  • 1.24
  • 1.48
  • 1.39
  • 1.58
  • 1.32
  • 1.53
icon
  • -4.41
  • 16.81
  • -8.10
  • 10.56
  • -19.37
  • 19.20
  • -6.10
  • 13.88
  • -16.35
  • 15.99
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
153,208
132,089
157,900
138,651
147,660
123,876
153,642
138,964
151,217
129,457
營業成本
47,54241,32049,11844,42245,57040,82050,98645,41347,57841,077
營業毛利
105,666
90,769
108,782
94,229
102,090
83,056
102,656
93,551
103,639
88,380
營業費用
86,53982,35389,29682,97883,72178,10691,44589,477--
研發費用
3,1732,4673,0072,9233,1723,0112,9593,8083,9582,597
推銷及管理費用
82,74078,32582,75778,65779,11073,50284,31481,57394,71678,701
非經常性項目費用
-4154542,235---2,4042,03131,870-
其他營業費用
1,0411,1071,2971,3981,4391,5931,7682,0652,0641,755
營業利益
18,712
8,416
19,486
11,252
18,368
4,869
10,919
4,074
-28,969
5,327
其他收入及費用
249427-37-404-562-858949626-159-63
利息費用
4,0684,3265,3066,1777,4947,5098,9979,5329,92410,339
稅前純益
15,308
4,517
14,143
4,670
10,313
-3,417
3,163
-4,832
-39,052
-5,075
所得稅
-20,897571-3,1756641,041-95550589-7,339907
稅後純益
33,441
3,113
14,755
3,155
7,459
-2,637
2,195
-4,824
-23,672
-4,570
基本每股稅後盈餘(元)
0.490.050.220.050.11-0.04--0.07-0.37-0.08
稀釋每股稅後盈餘(元)
0.480.040.210.050.11-0.04--0.08-0.40-0.08
基本平均股數(千股)
67869.0067296.0067019.0066924.0066500.0066008.0065451.0065258.0064056.0063380.00
稀釋平均股數(千股)
70838.0070008.0069261.0068837.0068536.0066008.0065451.0065258.0064056.0063380.00
還原基本每股稅後盈餘(元)
0.490.050.220.050.11-0.04--0.07-0.37-0.08
還原稀釋每股稅後盈餘(元)
0.480.040.210.050.11-0.04--0.08-0.40-0.08
還原基本平均股數(千股)
67,86967,29667,01966,92466,50066,00865,45165,25864,05663,380
還原稀釋平均股數(千股)
70,83870,00869,26168,83768,53666,00865,45165,25864,05663,380
EBITDA(千元)
27,55719,21528,58021,39928,04316,64224,14717,572-7,99718,461

大家都在看

HOT